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One of the best ways to disseminate research findings is to publish them in a respected 38 
peer-reviewed journal in the field. This is the goal of most researchers and as the impact 39 
factor of a journal rises, the number of submissions usually increases. This is the case for our 40 
society journal: Clinical Nutrition.  Unfortunately, the quest for a peer-reviewed publication 41 
in a high impact journal, tempts some researchers to cut corners, either knowingly or 42 
unknowingly. This is a dangerous practice and lack of publication governance could bring 43 
authors [1], co-authors [2], reviewers, editors [3] and journals into disrepute. We would like 44 
to highlight some instances of potential malpractice discovered in relation to articles 45 
submitted to Clinical Nutrition in the recent past and hope that this editorial will serve as a 46 
deterrent to such practices. 47 
 48 
Appropriate permissions 49 
● All prospective studies must have ethics committee/institutional review board 50 
(IRB)/animal licence approval prior to commencement. Other appropriate approvals, 51 
when necessary (e.g. Medicines & Healthcare products Regulatory Agency - MHRA), 52 
should also be in place. Although ethics committee/IRB approval may not be 53 
necessary for all retrospective studies, at the very least the protocol should be 54 
registered with the audit office (or similar body) of the institution and permission for 55 
the study should be obtained. The body providing approval and the approval number 56 
should be mentioned in the methods section of the manuscript. Retrospective 57 
registration is not acceptable. 58 
 59 
Consent 60 
● All participants in prospective studies must have provided informed written consent. 61 
Consent may not be essential for retrospective studies, but authors must provide 62 
evidence that they have obtained permission to use the data. 63 
 64 
The case of clinical trial/study registration 65 
● A  systematic review submitted recently included a statement that the protocol had 66 
been registered with an appropriate database 67 
(https://www.crd.york.ac.uk/prospero/). A registration number was provided, but 68 
this did not match the style of the database. When the database was searched, the 69 
protocol could not be found. 70 
● Recently a paper was submitted that had the correct reference to an approved 71 
clinical trial registration (https://clinicaltrials.gov). On checking with the registry, it 72 
was found that that the registered design of the study was different from what was 73 
reported in the submission. One group of participants had been omitted from the 74 
submitted paper. 75 
● It is also the duty of the authors to update the progress of the study and the results 76 
in the registry. 77 
 78 
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The case of not following the recommended method of reporting   79 
● Papers on randomised controlled trials and systematic reviews that have not 80 
adhered to the CONSORT (http://www.consort-statement.org) or PRISMA 81 
(http://www.prisma-statement.org) statement guidelines have been submitted. 82 
Other guidelines are available for other types of studies (e.g. STROBE statement 83 
guidelines for observational studies: https://strobe-84 
statement.org/index.php?id=strobe-home). Details of checklists appropriate for 85 
various types of studies can be found at the Enhancing the QUAlity and Transparency 86 
Of health Research (EQUATOR) Network website (http://www.equator-network.org).  87 
● The checklist submitted along with the paper must be accurate. In a recent 88 
submission, the authors stated in the CONSORT checklist that the sample size 89 
calculation was on page 5 of the manuscript. However, on checking the manuscript, 90 
there was no mention of sample size calculation anywhere. 91 
 92 
The case of authorship and “gift” authorship 93 
● A paper with 21 authors was submitted, with the contributions of at least 7 of them 94 
listed as “intellectual input”. The Committee on Publication Ethics (COPE) has 95 
guidelines on authorship and contributorship [4] and these should be adhered to. 96 
Authors should be involved in all stages of the research process and this includes 97 
protocol development, data collection/analysis/interpretation, writing of the 98 
manuscript, critical review and final approval of the submitted manuscript. 99 
Gratuitous and gift authorship is a dangerous practice as a potentially fraudulent 100 
publication could bring all authors into disrepute [5]. All authors must be in a 101 
position to take responsibility for the data presented and their interpretation, and 102 
should be able to defend the paper. Equally, excluding persons who may potentially 103 
qualify for authorship must also be avoided.  104 
● When the revised version of a paper was submitted, the editors found that one of 105 
the reviewers had been added to the list of authors. The authors were not aware 106 
that the person had reviewed the paper, but the reviewer had not been consulted by 107 
the authors, nor had he/she agreed to be an author. In addition, on review of the 108 
revised version, the reviewer did not notice the change in authorship. This led to the 109 
paper being rejected by the editors as the whole review process was severely 110 
compromised and rendered null and void. 111 
● We recently had a case in which a scientist who had a very substantial role in the 112 
study and writing of the manuscript was excluded from authorship. The paper had to 113 
be retracted because the authors could not agree on a change in authorship and 114 
some modification of the content of the manuscript. 115 
● Addition/deletion of authors when revisions are submitted must be avoided. If this is 116 
absolutely necessary, justification for this must be provided along with consent. 117 
● There should be a logical relationship between the number of co-authors and the 118 
work discussed. Some journals limit the number of co-authors to maximum of 8, 119 
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unless adequate justification can be provided. A large number of authors may be 120 
justifiable for large scale multi-centre trials, but this should not be the case for small 121 
single centre studies, especially when many authors from outside the institution are 122 
included. Co-workers who have contributed to some but not all aspects of the study 123 
can be added as collaborators or contributors rather than authors. Although the 124 
names of collaborators or contributors do not appear on the masthead, they will 125 
have a citable reference in Medline and other indexing databases. 126 
● Clinical Nutrition sends an email to all co-authors informing them that a paper has 127 
been submitted. If authors feel that they should not be an author on the paper or if 128 
they have not approved the submitted version, they should contact the journal 129 
office immediately. These disputes are easier to resolve at early stages in the 130 
submission process than after publication. 131 
● Ghost authors such as medical writers who help authors develop and write 132 
manuscripts should be mentioned in the acknowledgements 133 
(https://www.emwa.org/about-us/position-statements/ghostwriting-positioning-134 
statement/). Language editors should also be acknowledged. 135 
 136 
Declaration of interests 137 
● There have been several instances of the declaration of interests forms not being 138 
filled in by the individuals concerned, but being proxied by the corresponding 139 
author. It is vital that the individual authors complete the declaration of interests 140 
forms themselves and declare all direct, indirect and potential conflicts of interest. 141 
These need not be directly related to the paper under consideration, but must be 142 
stated in the interests of transparency [6]. 143 
 144 
The case of plagiarism and self-plagiarism  145 
● Several instances of plagiarism and self-plagiarism [7] have been detected. The 146 
journal runs an electronic check on all papers submitted and cases of plagiarism and 147 
self-plagiarism are flagged automatically. 148 
● Recently the same group of authors submitted two papers using the same study 149 
design on two different groups of patients. The plagiarism check highlighted >60% 150 
overlap of text between the two papers. 151 
● Editors usually apply discretion and common sense, but high levels of overlap may 152 
lead to rejection of papers. 153 
 154 
The case of duplicate publication 155 
● The results of a study were submitted by two different researchers from the same 156 
team in two different journals, one paper was already published, while the other 157 
submission was still under consideration. This was of course noticed, and a major 158 
dispute followed. Finally, the published paper was modified to include the authors of 159 
the submitted paper, while also updating some of the information in the paper. This 160 
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was only possible protracted discussion with the authors. The alternative would have 161 
been retraction of the published paper and that was something the authors wanted 162 
to avoid. Dual or duplicate publication is not a rare practice and must be avoided at 163 
all costs [8]. 164 
 165 
The case of salami slicing 166 
● While it is tempting to publish more than one paper from a single study, it is 167 
preferable to combine the results into one paper rather than duplicate them. This 168 
practice of salami slicing should be avoided [9]. Sometimes it may be justified to 169 
publish more than one paper from a single study, provided these are very different. 170 
In this situation, the authors should mention this upfront and submit a copy of the 171 
published/accepted paper so that the reviewers and editors may make an informed 172 
judgement. 173 
 174 
The case of intellectual property and reporting 175 
● In a paper, the proprietary name of a nutritional supplement was mentioned and 176 
studied, but product name was used without approval from the owners of the 177 
original supplement composition trademark. This is comparable to the situation in 178 
which a product named XYZ has been sold and another company makes a product 179 
with the same name, but with a different composition, but still uses the available 180 
marketing information and brand name recognition of the original product XYZ. This 181 
is an example of the need to be very careful when studying commercial products 182 
without knowledge of the validity of the product. In this instance there was a 183 
protracted dispute between the two companies and the authors, with the 184 
publication of corrigenda.  185 
 186 
The question of apportioning blame 187 
● When problems were discovered with a recent paper, the senior author blamed an 188 
overenthusiastic first author for the misdemeanour. It must be remembered that the 189 
ultimate responsibility for the integrity of a paper rests with all authors. However, 190 
the first, senior and corresponding authors have primary responsibility for ensuring 191 
that communication between all authors occurs and potential misdemeanours are 192 
avoided. 193 
 194 
The case of incorrect citations 195 
● Incorrect references supporting statements made in manuscripts have been found. It 196 
is the responsibility of authors to ensure that the references are both correct and 197 
accurate [10]. 198 
● Inaccurate interpretation of published work must also be avoided. 199 
● In a recently submitted systematic review, the authors chose to omit a number of 200 
eligible studies without providing a reason. This was detected and the paper was 201 
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● While it is understood that reviewers provide a very valuable service to the journal 206 
and that their time is not compensated for, it would be appreciated if reviewers 207 
would decline to review as soon as they receive an invitation if they feel they do not 208 
have the time or if the manuscript is outside their field of expertise. 209 
● However, once reviewers have accepted an invitation, it would also be appreciated if 210 
they would submit their reviews on time. 211 
● Reviewers should decline invitations if they feel that they have a conflict of interest 212 
(e.g. if they are a rival of the authors, if they have collaborated with or have joint 213 
publications with the authors, or if they have financial or other interests in the paper 214 
submitted). 215 
● An insightful evaluation of the manuscript helps the editors make an appropriate 216 
decision. One line comments such as “this is a good paper: accept” or “this is a very 217 
poor paper: reject” are not very helpful (https://www.elsevier.com/reviewers/how-218 
to-review). 219 
 220 
Sanitising the reviewers’ comments 221 
● In the rebuttal letter to reviewers, some authors choose to delete the comments 222 
that they do not wish to reply to. This is unacceptable practice. While it is not 223 
necessary for authors to make all the changes suggested by reviewers, authors 224 
should make it clear why they have chosen not to modify the manuscript in response 225 
to certain comments. 226 
 227 
Author email addresses 228 
● Ideally institutional email addresses rather than generic email addresses (e.g. 229 
hotmail, gmail, yahoo, etc.) should be provided in the submission details. Generic 230 
email addresses may be acceptable in certain circumstances, e.g. when an author is 231 
in the process of changing institutions. 232 
 233 
Errors and omissions 234 
● Authors are human and honest errors do occur. When these errors are found after 235 
publication, it is the duty of authors to submit a timely corrigendum to the journal 236 
and rectify the errors [11]. 237 
● Serious errors may involve self-retraction of the paper by the authors. 238 
 239 
Potential consequences 240 
These practices, whether intentional or not, pose serious problems and also result in a huge 241 
waste of time of both the reviewers and the editors. In serious cases, the Dean/Head of the 242 
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Institution where the authors work will be informed. At the extreme, misdemeanours could 243 
lead to retraction of papers, disciplinary action against authors or even termination of 244 
academic appointments.  245 
 246 
Some advice 247 
Case studies in publication misdemeanour that have led to retraction of papers and/or 248 
disciplinary action against authors can be found at https://retractionwatch.com. Authors are 249 
also advised to study the COPE guidelines (https://publicationethics.org) and also the 250 
checklists provided by the EQUATOR Network (http://www.equator-network.org) before 251 
drafting their manuscripts. They should also read the instructions to authors provided by 252 
the journal and ensure that their submissions conform to them. While all authors should 253 
assume responsibility for submissions, it is primarily the responsibility of the first, senior and 254 
corresponding authors to vouch for the authenticity of the submission and to ensure that all 255 
aspects of research and publication governance have been adhered to. 256 
 257 
Authors remain responsible for the content of the publication. The publisher, the editorial 258 
board and the reviewers do not have primary responsibility for the content of the 259 
publication. Their role is to help the author to have the best possible publication. Even when 260 
an author is a very respected scientist with 500 publications, one publication of the 500 that 261 
has problems similar to those discussed in this editorial, can lead to the remaining 499 262 
publications being viewed with a different perspective, and this usually includes suspicion 263 
and greater scrutiny. When publication misdemeanour (e.g. falsified results, 264 
misinterpretation of data, manipulated figures, etc.) has been proven, all publications of all 265 
authors will be scrutinised and this usually leads to finding more publications with problems 266 
[1, 2]. Therefore, all authors remain responsible for the content of the publication.  267 
 268 
Conclusion 269 
It is hoped that this editorial will help authors understand some of the potential pitfalls 270 
associated with publication and will enable them to submit better papers. Paying attention 271 
to detail will speed up the review process and also result in higher acceptance rates. It will 272 
also avoid disputes which, sometimes, can be acrimonious, result in retraction of papers 273 
[12] and lead to disciplinary action. 274 
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